Screener / SEC EDGAR /CIK 0000822663 /10-K filed Mar 10, 2026, compared with Mar 11, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Consumer staples · Cosmetics

Interparfums Inc IPAR

Compare with peers Embed
New in the 10-K 6 paragraphs with nothing like them in the 10-K filed Mar 11, 2025 New in the 10-Q 29 paragraphs not in the 10-Q filed Aug 4, 2026 10-Q against the 10-K 0 risk factor paragraphs and sentences added or reworded

New risk paragraphs, branching off last year

Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Mar 11, 2025. A box jumps to the paragraph as filed, below.

6 new

Paragraphs with nothing like them in last year's 10-K

Quoted exactly

6 paragraphs in Risk Factors of the 10-K filed Mar 10, 2026 with nothing like them in the 10-K filed Mar 11, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.

During fiscal 2025, we implemented a number of remediation actions designed to strengthen our internal control environment, including enhancing our control environment and monitoring procedures, improving documentation and evidence of control operating effectiveness, strengthening information technology general controls, and implementing a formal enterprise-wide risk assessment process. Based on testing performed by management, we concluded that certain previously reported material weaknesses related to the control environment and information technology general controls were remediated as of December 31, 2025. However, a material weakness related to the design and implementation of our risk assessment process remains as of December 31, 2025.

Read in the 10-K

Any failure to maintain effective internal control over financial reporting could subject us to litigation or investigations, require management resources and payment of legal and other expenses, negatively affect investor confidence in our financial statements, and adversely impact the market price of our common stock.

Read in the 10-K

Our IT Systems require an ongoing commitment of significant resources to maintain, protect, and enhance to keep pace with continuing changes in technology, regulatory standards, and cyber threats, as well as new commercial opportunities. From time to time, we undertake significant information technology systems reviews, as well as projects, such as enterprise resource planning updates, modifications, integrations and rollouts. These projects may be subject to cost overruns and delays that may cause disruptions in our normal business operations. These cost overruns and delays as well as our reliance on third party contractors for certain software implementation, maintenance and upgrades for certain business and financial information could adversely affect our business and results of operations.

We have started using artificial intelligence (“AI”), and improper use by us or third parties could have an adverse impact on our brands, business and results of operations.

We have started using AI to assist in the development and marketing of our products. This evolving technology presents risks inherent in its use, including risks related to inaccuracies, bias, and infringement of intellectual property. In addition, the use of AI could potentially increase cybersecurity and data privacy risks, such as unintended access to and transmission of proprietary or sensitive information. These risks may become more pronounced as we increase our reliance on AI.

We cannot assure that our usage of AI will assist us in being more efficient in all cases. Our competitors or other third parties may incorporate AI into their business, services, and products more rapidly or more successfully than us, which could hinder our ability to compete effectively and adversely affect our business. As AI is an emerging technology and new laws and regulations are being promulgated, and our obligation to comply with this evolving regulatory landscape could entail significant costs.

Read in the 10-K

Paragraphs in the 10-Q filed Nov 4, 2026 that were not in the one before

New in the latest 10-Q

29 paragraphs in the 10-Q filed Nov 4, 2026 with nothing like them in the 10-Q filed Aug 4, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.

Financial statements and notes

Adjustments to reconcile net income to net cash used in (provided by) operating activities:

Read in the 10-Q

Accounts receivable represents payments due to the Company for previously recognized net sales reduced by allowances for credit losses and customer deductions totaling $375.4 million, $320.6 million, $274.7 million as of September 30, 2026, December 31, 2025, and December 31, 2024, respectively. We generally grant credit based upon our analysis of the customer’s financial position, as well as previously established buying patterns. The Company estimates expected credit losses based on historical credit loss experience, the aging of outstanding receivables, customer-specific credit risk, current economic conditions, credit insurance coverage, and reasonable and supportable forecasts, as applicable. The allowance is reviewed periodically and adjusted as necessary based on changes in credit risk and collection experience. The allowance for credit losses was $4.1 million and $3.2 million as of September 30, 2026 and December 31, 2025, respectively. Accounts receivable balances are written off against the allowance for credit losses when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received.

Read in the 10-Q

During the second quarter of 2026, the Company corrected an immaterial misclassification in the presentation of equity related to Interparfums SA share-based compensation. The correction resulted in a $12.9 million reclassification from retained earnings to noncontrolling interest and had no impact on net income, operating income, cash flows, total assets, total liabilities, or total equity. The correction is reflected in the “Reclassification adjustment” line in the accompanying Statement of Changes in Shareholders’ Equity. Refer to the Company’s Form 10-Q for the quarter ending June 30, 2026 for additional information regarding the correction.

Read in the 10-Q

The Company is exposed to foreign currency risk associated with its net investment in certain foreign operations. The Company uses euro-denominated borrowings to manage a portion of the foreign currency exposure associated with its net investment in Interparfums SA ("IPSA"), whose functional currency is the euro.

Read in the 10-Q

As of September 30, 2026, the Company had €55.0 million ($62.5 million) of euro-denominated borrowings outstanding under its €200 million senior secured credit facility. The Company designated €55.0 million of these borrowings as nonderivative hedging instruments in net investment hedges of corresponding portions of the Company's net investment in IPSA.

Read in the 10-Q
Show the other 24

Foreign currency transaction gains and losses attributable to the qualifying designated borrowings are recognized in the cumulative translation adjustment component of accumulated other comprehensive income rather than in current-period earnings. Such amounts remain in accumulated other comprehensive income until the applicable reclassification requirements associated with the hedged net investment are met.

Read in the 10-Q

For the three and nine months ended September 30, 2026, the Company recognized $1.4 million of unrealized foreign currency gain associated with the designated net investment hedges in foreign currency translation adjustments in the accompanying statement of comprehensive income. No amounts were reclassified from accumulated other comprehensive income into earnings during the periods presented.

Read in the 10-Q

The Company and its domestic subsidiaries have credit lines totaling $34.1 million (€30 million) provided by an international financial institution. This credit line bears interest at the Euribor plus a margin of 1.65%.

Read in the 10-Q

The Company and its domestic subsidiaries have credit lines totaling $45 million provided by a consortium of domestic financial institutions. These credit lines bear interest at the Secured Overnight Financing Rate ("SOFR") plus a margin.

Read in the 10-Q

Borrowings outstanding pursuant to these lines of credit were zero as of September 30, 2026 and December 31, 2025.

Read in the 10-Q

The weighted average interest rate on these short-term borrowings was 4.3% and 5.2% as of September 30, 2026 and December 31, 2025, respectively.

Read in the 10-Q

$34.1 million (€30 million) payable in 72 monthly installments of approximately $0.5 million each beginning in June 2025, bearing interest at one-month Euribor plus 0.88% 26,495 31,819

Read in the 10-Q

$22.7 million (€20 million) payable in 72 monthly installments of approximately $0.3 million each beginning in June 2025, bearing interest at 3.0% per annum 18,016 21,401

Read in the 10-Q

$45.4 million (€40 million) payable in 36 monthly installments of approximately $1.3 million each beginning in August 2024, bearing interest at 4.03% per annum 13,181 25,525

Read in the 10-Q

$56.8 million (€50 million) payable in 48 equal monthly installments of $1.2 million beginning in December 2022, bearing interest at one-month Euribor plus 0.825% 2,363 13,463

Read in the 10-Q

$136.3 million (€120 million) payable in 120 equal monthly installments of $1.2 million beginning in April 2021, bearing interest at one-month Euribor plus 0.75% 61,062 73,731

Read in the 10-Q

$17.0 million payable (€15 million) in 10 equal annual installments of $1.8 million beginning in October 2021 including interest imputed at 2.0% per annum 8,164 10,089

Read in the 10-Q

On August 12, 2026, the Company entered into a €200 million senior secured credit facility with a syndicate of lenders to finance the share repurchase program disclosed in Q2 2026 10-Q and related transaction costs. The Facility Agreement provides for an availability period during which the Company may draw funds in one or more euro-denominated borrowings, subject to the terms and conditions of the agreement.

Read in the 10-Q

During the availability period, the facility operates as a delayed-draw credit facility. Borrowings bear interest at variable rates based on three-month EURIBOR plus a contractual margin determined by the Company's leverage ratio. The effective interest rate on the credit facility was 3.81%, as of September 30, 2026. The Facility Agreement requires the Company to pay a commitment fee of 0.42% per annum on the undrawn portion of the facility during the availability period. Interest and commitment fees incurred during the availability period are either paid when due or added to the outstanding loan balance upon conversion to a term loan.

Read in the 10-Q

Upon the end of the availability period or an earlier election by the Company in accordance with the Facility Agreement, the facility converts into a long-term amortizing term loan. Upon conversion, outstanding borrowings, accrued interest and certain unpaid fees are combined into a single term loan balance. An amount equal to one-twenty-first (1/21) of the outstanding principal balance becomes immediately due upon conversion, with the remaining balance amortized ratably over twenty subsequent quarterly installments. The facility matures on August 2032.

Read in the 10-Q

In connection with obtaining the financing, the Company incurred approximately €1.14 million of deferred financing fees which were capitalized as original issue discounts and included in the carrying amount of the debt in the Consolidated Balance Sheet. Capitalized fees are amortized over the life of the debt under the straight-line method and are included in interest expense.

Read in the 10-Q

The Facility Agreement contains a financial maintenance covenant requiring the Company to maintain a leverage ratio not exceeding 3.0x, measured annually using the Company's consolidated audited financial statements. Failure to comply with the covenant may constitute an event of default, subject to any applicable cure rights, waivers or amendments available under the Facility Agreement.

Read in the 10-Q

As of September 30, 2026, the Company had drawn €55.0 million under the facility and had €145.0 million of the remaining borrowing capacity available under the Facility Agreement.

Read in the 10-Q

In June 2025, IPSA entered into a $34.1 million (€30 million) three-year loan agreement bearing interest at a variable rate of one-month EURIBOR plus a margin of 0.88% and a $22.7 million (€20 million) three-year loan agreement bearing interest at 3.0% per annum. In July 2024, IPSA entered into a $45.4 million (€40 million) three-year loan agreement bearing interest at 4.03% per annum. The proceeds from these loans were used to improve the Company's short-term cash position.

Read in the 10-Q

For United States based operations, sales in the three months ended September 30, 2026 decreased 7% compared to the corresponding period of the prior year, driven largely by supply chain disruptions that resulted in the delayed shipment of giftsets for select brands. These delays represented approximately $10 million in sales, which will now be recognized in the fourth quarter. Excluding this impact, sales would have been flat. Year-to-date sales grew 3% in 2026, driven by 2% organic growth and a favorable foreign exchange impact of 1%. Excluding the impact of the delayed giftset shipments, sales would have increased 6%. Fragrance sales of GUESS, our largest United States based brand, rose by 3% and 7% during the third quarter and first nine months of 2026, respectively. Growth was driven by the continuing success of the Iconic franchise which was enhanced by the launches of two new extensions earlier this year, as well as extensions launched for the Amore and Seductive franchises. Donna Karan/DKNY fragrance sales declined 9% during the third quarter following double digit growth in the second quarter of 2026. The third quarter sales decline was driven by innovation phasing and giftset shipment delays. Brand sales grew 4% in the first nine months of the year. Ferragamo fragrance sales declined 22% in the third quarter due to innovation phasing but were only down 2% on a year-to-date basis. The brand was impacted by challenging market conditions in Europe, which is the core region for the brand. Roberto Cavalli fragrance sales increased 4% and 6% during the third quarter and first nine months of 2026, respectively, despite a difficult macro-economic environment in the Middle East, the brand’s largest market, and exceptionally high prior year growth comparisons. The brand’s growth this year has been driven by the enduring popularity of last year’s blockbuster Serpentine launch, as well as brand extensions released earlier in 2026, and the partnership with Kiko Milano.

Read in the 10-Q

Our global brand portfolio and diverse fragrances enable us to reach a wide range of consumers and pursue multiple avenues for growth, with strength across key brands and markets helping to offset softer demand elsewhere. We are aligning our product offerings and commercial strategies with evolving consumer preferences. We are investing in our future with expanded partnerships and new exclusive license agreements, while preparing for a promising 2026 holiday season and an exciting 2027, driven by a series of blockbuster launches and new brand additions. While some aspects of the market environment remain challenging, we are encouraged by the trajectory of our business and maintain a measured but positive outlook for the balance of the year, 2027 and beyond.

Read in the 10-Q

Gross Profit Margin Three Months Ended September 30, Nine Months Ended September 30,

Read in the 10-Q

On August 12, 2026, the Company entered into a €200 million senior secured credit facility with a syndicate of lenders to finance the share repurchase program disclosed in Q2 2026 10-Q and related transaction costs. As of September 30, 2026, the Company had drawn €55.0 million under the facility and had €145.0 million of the remaining borrowing capacity available under the Facility Agreement.

Read in the 10-Q

During the third quarter of 2026, the Company invested approximately $49.5 million to acquire additional shares of Interparfums SA, its Paris-based subsidiary listed on Euronext Paris, under this program, increasing its ownership interest from approximately 72.5% to 74.3%.

Read in the 10-Q

The 10-Q's risk factors against the 10-K

Item 1A of the 10-Q filed Nov 4, 2026 against Item 1A of the 10-K filed Mar 10, 2026. A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed. Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed, Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal (cut words struck through, new words highlighted). Text on the page, not a score; each links to the filing at sec.gov.

What the 10-Q itself says about its risk factors:Information regarding our Risk Factors can be found in our 2025 Annual Report on Form 10-K filed with the SEC.

Read in the 10-Q

1 paragraph in the 10-Q's Item 1A, and none of them adds, rewords or quietly edits a paragraph of the 10-K's.

Phrases used for the first time

Two-word phrases in Risk Factors of the 10-K filed Mar 10, 2026 that are in none of the 1 earlier 10-Ks stored, back to Mar 11, 2025

control environment ×3assessment process ×2technology systems ×2cost overruns ×2
Where each one is used
  • control environment: During fiscal 2025, we implemented a number of remediation actions designed to strengthen our internal control environment, including enhancing our control environment and monitoring procedures, improving documentation and evidence of control operating effectiveness, strengthening information technology general...
  • assessment process: During fiscal 2025, we implemented a number of remediation actions designed to strengthen our internal control environment, including enhancing our control environment and monitoring procedures, improving documentation and evidence of control operating effectiveness, strengthening information technology general...
  • technology systems: We have information technology systems (“IT Systems”) that support our business processes, including product development, production, marketing, order processing, sales, distribution, finance and intra-company communications. We also have Internet websites in the United States and Europe. These systems may be...
  • cost overruns: Our IT Systems require an ongoing commitment of significant resources to maintain, protect, and enhance to keep pace with continuing changes in technology, regulatory standards, and cyber threats, as well as new commercial opportunities. From time to time, we undertake significant information technology systems...

The 10-K at sec.gov

Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.

Sources

Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.

Also

10-K change: what was reworded or cut, section by section.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IPAR/export.csv") into a cell.

Next:10-K change
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.